@MicrobiomeFirst Trial in #asthma 'folk' is up and running, see clinicaltrials.gov/ct2/show/NCT03… for more info including eligibility and participating sites
English
4D pharma
222 posts
4D pharma
@4dpharmaplc
Leader in Live Biotherapeutics NASDAQ: $LBPS AIM: $DDDD
Leeds, UK Beigetreten Nisan 2016
132 Folgt2.3K Follower
@MicrobiomeFirst It's going pretty well so far @MicrobiomeFirst ! World first data recently presented at #ATS2022
4dpharmaplc.com/en/newsroom/pr…
English
How can we turn the "someday will prevent" to "today we are pleased to "announce"? How far are we @4dpharmaplc? You have a clinical trial on #asthma, how's that going?
4D pharma@4dpharmaplc
This month's @ScienceMagazine Special Issue: The Systemic Microbiome. "Understanding the ecology and the mechanisms of cross-talk between host and microbiota will one day contribute to preventing and treating a spectrum of human diseases." science.org/toc/science/37…
English
This month's @ScienceMagazine Special Issue: The Systemic Microbiome.
"Understanding the ecology and the mechanisms of cross-talk between host and microbiota will one day contribute to preventing and treating a spectrum of human diseases."
science.org/toc/science/37…
English
We are pleased to be presenting our Phase II trial of #LiveBiotherapeutic MRx0518 with Bavencio as a first-line maintenance therapy for #UrothelialCarcinoma at #ASCO22
Session: Genitourinary Cancer - Kidney and Bladder. Saturday, June 4, 2022 at 13:15 CDT
$LBPS #DDDD
English
On #clinicaltrialsday , @ParkinsonsUK have written about one of 4D pharma's lunch and learn sessions, highlighting the importance of engaging patients in clinical research.
tinyurl.com/2p9bfsuj
#microbiome #DDDD $LBPS
English
Results from Part A of @4dpharmaplc's trial of #LiveBiotherapeutic MRx-4DP0004 for the treatment of #asthma have been selected as a late-breaking abstract at #ATS2022 @atscommunity
These results support the potential of MRx-4DP0004 as a novel oral immunomodulator asthma therapy
English
CEO Duncan Peyton stopped by the #BusinessOfBiotech podcast with @mattpillar @BioProcessOL @Cytiva to discuss how @4dpharmaplc is defining a new class of drug with our #LiveBiotherapeutics and the challenges overcome along the way
bit.ly/3KMTozs
#microbiome #DDDD $LBPS
English
On #WorldParkinsonsDay we are proud to be working with @ParkinsonsUK to raise awareness and support research into new therapies for #Parkinsons
Brave souls from @4dpharmaplc will be attempting the infamous @ToughMudder and you can show your support at:
justgiving.com/fundraising/4d…
English
Today Dr Imke Mulder, EVP Research, will present at the Microbiome & Probiotics R&D and Business Collaboration Forum #MicrobiomeForum on developing #LiveBiotherapeutics for neurodegenerative disease as we look ahead to initiating a first-in-human trial in #Parkinsons in 2022
English
Join us in 30 minutes us for a conference call and webcast to discuss this morning's results for MRx0518 and Keytruda in renal cell carcinoma (RCC) and current treatment landscape, alongside KOLs @PGrivasMDPhD and @DrScottTagawa
Register via 4dpharmaplc.com/en/newsroom/ev…
$LBPS #DDDD
4D pharma@4dpharmaplc
Today we announced the #renalcellcarcinoma group in Part B of our Phase I/II study of #LiveBiotherapeutic MRx0518 with #Keytruda has met the primary efficacy endpoint ahead of full enrollment. Read the full release at 4dpharmaplc.com/en/newsroom/pr… $LBPS #DDDD
English
Today we announced the #renalcellcarcinoma group in Part B of our Phase I/II study of #LiveBiotherapeutic MRx0518 with #Keytruda has met the primary efficacy endpoint ahead of full enrollment.
Read the full release at 4dpharmaplc.com/en/newsroom/pr…
$LBPS #DDDD
English
4D Gets Green Light to Test First Live Biotherapeutic for Parkinson's
"With IND approval, the therapeutics have become the first LBPs for Parkinson’s disease cleared by the FDA"
@biospace #Parkinsons #microbiome #GutBrainAxis #DDDD $LBS
biospace.com/article/4d-get…
English
MRx0005 and MRx0029 #Parkinsons IND approvals covered in today's BioPharma Reporter, as well as a re-cap of our #asthma data released in January for MRx-4DP0004
biopharma-reporter.com/Article/2022/0…
#DDDD $LBPS
English
Today we announced that the US FDA has cleared IND applications for @4dpharmaplc’s #LiveBiotherapeutics MRx0005 and MRx0029 for the treatment of #Parkinsons, and Phase I trial in patients is expected to commence mid-2022
4dpharmaplc.com/en/newsroom/pr…
#GutBrainAxis #microbiome
English
Today marks @uicc World Cancer Day - raising awareness of one of the leading causes of death worldwide.
4D Pharma are proud to contribute to helping patients through developing novel and safe LBPs. Learn more at tinyurl.com/4DLBPS
#WorldCancerDay #Cancer #DDDD $DDDD $LBPS
English
English
Today @4dpharmaplc will discuss how we are developing #LiveBiotherapeutics targeting the #GutBrainAxis to treat #Parkinsons at an event hosted by North of Scotland Parkinson’s Research Interest Group (NoSPRIG) and Dundee Research Interest Group (DRIG)
parkinsons-org-uk.zoom.us/meeting/regist…
English
#ICYMI Replays of two recent events available via the Events page of our website at 4dpharmaplc.com/en/newsroom/ev…
- 27 Jan, MRx-4DP0004 #Asthma Phase 1/2 Part A Results with Prof. Chris Brightling
- 31 Jan, #LiveBiotherapeutics for #Parkinsons, hosted by NoSPRIG, DRIG, @ParkinsonsUK
English
We caught up with @GENbio to discuss how @4dpharmaplc approaches the development of 'Bacteria as Therapeutics', from the MicroRx platform and #LiveBiotherapeutic discovery, to in-house manufacturing and clinical development
genengnews.com/topics/bioproc…
#DDDD $LBPS #microbiome
English